Retractable Technologies, Inc. (RVP) Q3 Sales Rise 40%, Operating Loss Widens to $4.1M
Retractable Technologies (RVP) reported Q3 2026 sales of $14.1M, up 40% YoY, but operating loss widened to $4.1M. Nine-month sales were nearly flat at $28.5M, with an operating loss of $15.5M. The company attributes the quarterly sales recovery to unusual flu-season timing and notes that sustained improvement is needed.
How this was made

The 30-second read
Why it matters
For traders, the key decision is whether the sales rebound is sufficient to offset cost pressure, and whether the company is on a path to margin improvement in upcoming quarters.
Market read
A company-specific quarterly update with concrete revenue and operating-loss figures, but no guidance or balance-sheet detail to confirm a sustained turnaround.
What to watch
The article does not provide gross margin, cash flow, or guidance, so traders may be over-weighting operating loss without knowing whether costs are controllable in subsequent quarters.
Background
The piece frames Q3 as a recovery versus a year-ago quarter affected by unusual flu-season timing, while nine-month sales are nearly flat and losses widen.
Ticker impact
Retractable Technologies reports Q3 2026 sales up to $14.1M from $10.1M, while operating loss widens to $4.1M from $3.7M.
Likely mixed-to-negative reaction as investors weigh improving top-line against expanding operating loss.
The article provides both the sales rebound and the deterioration in operating loss, which typically tempers optimism until margin and cost discipline improve.
Market effects
Signals ongoing profitability pressure despite sales stabilization for medical device or healthcare services peers with similar cost structures.
No clear regional spillover indicated beyond the issuer’s own performance.
Limited, as the article contains no guidance, macro drivers, or cross-border deal/regulatory catalysts.
Counterpoint
The widened operating loss could reflect temporary cost timing (e.g., inventory, flu-season effects, or one-time expenses), so the revenue rebound may still be the more durable signal.
Key entities
- companyRetractable Technologies, Inc.
Reports Q3 2026 sales growth and a wider operating loss, with nine-month sales nearly flat and losses increasing.

